360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

MannKind Corp

Type: Company

Name: MannKind Corp

Nationality: United States

Web Address: http://www.mannkindcorp.com/

Fact Sheet: Fact Sheet for MannKind Corp

First reported 18 hours ago - Updated 2 hours ago - 1 reports

FDA Food & Drug Administration

Biotech Companies: The FDA Doesn't Care About Your Phase 3 Trials

Keep track of the stocks that matter to you.Help yourself with the Fool's FREE and easy new watchlist service today. You read that right. Not up 33% because its phase 3 trial was a success. Up 33% because it's starting a phase 3 trial.Now granted, Peregrine ... [Published Motley Fool - 18 hours ago]

Entities: Peregrine Pharmaceuticals Inc, FDA Food & Drug Administration, Biotechnology

First reported May 19 2013 - Updated 17 hours ago - 3 reports

Pfizer Inc

Can Pfizer’s Love Hormone Cut Down Maternal Mortality?

Oxytocin is a brain chemical that helps the uterus contract after birth and is occasionally referred to as the “love hormone” because of its role in couples’ bonding. Used preventatively, it can actually cut the rate of post-delivery bleeding complications ... [Published Wall St. Cheat Sheet - 17 hours ago]

Entities: Pfizer Inc, Oxytocin, Hormone

First reported May 19 2013 - Updated May 19 2013 - 1 reports

MannKind Corp

MannKind Corporation (MNKD): Why Have Shares Moved?

MannKind Corporation (NASDAQ:MNKD) took one giant leap over the past few days. Shares have soared more than 30% since last week, after the company reported results for the first quarter. Was the news that great? Not really.It wasn’t that there was bad ... [Published InsiderMonkey.com - May 19 2013]

Entities: MannKind Corp, Stocks, Eli Lilly & Company

First reported May 19 2013 - Updated May 19 2013 - 1 reports

Aegerion Pharmaceuticals Inc

The Best- And Worst- Performing Biotech Stocks, May 10 To May 17

These are the best and worst-performing medical and biotech stocks from May 10 to May 17, 2013. This screen includes biotechnology and medical companies traded on the New York Stock Exchange, the Nasdaq or the American Stock Exchange that had market capitalizations ... [Published Forbes.com - May 19 2013]

Entities: Biotechnology, Stocks, Aegerion Pharmaceuticals Inc

First reported May 19 2013 - Updated May 19 2013 - 1 reports

Infinera Corp

5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's biggest scorchers. Let's start with SolarCity. This company is an installer of solar energy panels with a unique pricing model, allowing buyers to pay in monthly ... [Published Motley Fool - May 19 2013]

Entities: Infinera Corp, E-Commerce China Dangdang Inc, MannKind Corp

First reported May 18 2013 - Updated May 18 2013 - 1 reports

Motley Fool

1 Giant Leap for MannKind

The single, easiest way to keep track of all the stocks that matter...Your own personalized stock watchlist!It's a 100% FREE Motley Fool service... It wasn't that there was bad news. Actually, nothing announced by MannKind last week came as a big surprise. ... [Published Motley Fool - May 18 2013]

Entities: MannKind Corp, watchlist, Clinical trials, Motley Fool

First reported May 18 2013 - Updated May 18 2013 - 3 reports

Why MannKind's Afrezza Will Succeed Where Pfizer Failed

Home » Blogs » According to the American Diabetes Association over 25 million people in the US alone have diabetes and the numbers keep on growing. Although insulin injections have come a long way, poking yourself with a needle in public still draws unwanted ... [Published BioPortfolio - May 18 2013]

Entities: MannKind Corp, Pfizer Inc, Insulin, Exubera, Inhalation

First reported May 18 2013 - Updated May 18 2013 - 1 reports

Puma, Mannkind Among Week’s Biggest Movers

The Los Angeles Business Journal’s index of largest local public companies continued to gain this week, in line with the larger markets.The weighted LABJ Stock Index rose 1 percent to 169.07 for the trading week ending May 17. Gainers outpaced decliners ... [Published Los Angeles Business Journal - May 18 2013]

Entities: MannKind Corp, antineoplastic, Bellisio Foods, Puma Biotechnology Inc

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Form 4 MANNKIND CORP For: May 15 Filed by: PFEFFER MATTHEW J

StreetInsider.com - Form 4 MANNKIND CORP For: May 15 Filed by: PFEFFER MATTHEW J ... [Published Street Insider - May 17 2013]

Entities: MannKind Corp, Pfeffer

First reported May 17 2013 - Updated May 17 2013 - 1 reports

MannKind to Present at Bank of America Merrill Lynch 2013 Health Care Conference

(NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced that it will present at the Bank of America Merrill Lynch ... [Published NewsRX - May 17 2013]

Entities: MannKind Corp, Bank of America Merrill Lynch, Health Care

First reported May 15 2013 - Updated May 15 2013 - 2 reports

A Second Chance For Mannkind Co. (MNKD)?

(By Rich Bieglmeier) MLV Capital initiated coverage on MannKind Co. (MNKD) with a "buy" rating and a $6.00 price target on the stock – 18.8% upside as we type.MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and ... [Published I Stock Analyst - May 15 2013]

Entities: MannKind Corp, Insulin, Biotechnology, Diabetes

First reported May 15 2013 - Updated May 15 2013 - 2 reports

Activision Halts Vivendi Talks and 2 More Heavily Traded Stocks to Follow

Activision Blizzard ( NASDAQ:ATVI ): Current price $14.90Knowledgeable sources say that the video game publisher has halted talks on repurchasing shares held by its parent company Vivendi, amid a dispute over price adding that Activision was considering the ... [Published Wall St. Cheat Sheet - May 15 2013]

Entities: Vivendi SA, Activision Inc, Stocks, MannKind Corp

Quotes

"According to many online sources, Afrezza was about to be approved at the end of 2010. In fact, an FDA employee, Chang Yi Liang traded on the "inside information" after reading the confidential approval notice on internal email."

A Second Chance For Mannkind Co. (MNKD)? [Published I Stock Analyst - May 15 2013]

More From BioPortfolio on "MannKind to Present at Bank of America Merrill Lynch 2013 Health Care Conference"

MannKind to Present at Bank of America Merrill Lynch 2013 Health Care Conference [Published BioPortfolio - May 08 2013]

"The first rechargeable pacemakers were made here. The insulin pumps were also made right here, in these clean rooms" Greenberg said. "This place has incredible karma."

Bionic eye maker has vision of the future [Published Macon Telegraph - May 06 2013]

The abstract of the patent published by the U S Patent and Trademark Office states: "A handle for a safety razor is provided that includes an elongated hand gripping structure with a cartridge support structure at an end of the hand gripping structure. The hand gripping structure includes a frame and a first and second gripping pad. Each gripping pad can have a thermoplastic elastomeric gripping layer and a nonelastomeric thermoplastic support layer. The first gripping pad has an extension that cooperates with an opening of the frame to provide a snap fit joint between the frame and the first gripping pad. The second gripping pad has an extension that cooperates with the extension of the first gripping pad to prevent disengagement of the snap fit from the opening of the frame. The extension of the first gripping pad can be bifurcated and the extension of the second gripping pad can be received in the bifurcation."

U.S. Patents Awarded to Inventors in Connecticut (April 29) [Published Equities.com - Apr 29 2013]

More Content

sort by: Date \| Relevance
Can Pfizer’s Love Hormone Cut Down Maternal Mor... [Published Wall St. Cheat Sheet - 17 hours ago]
Can Pfizer’s Love Hormone Cut Down Maternal Mor... [Published Wall St. Cheat Sheet - 17 hours ago]
Biotech Companies: The FDA Doesn't Care About Y... [Published Motley Fool - 18 hours ago]
FDA Approves Oramed Pharmaceuticals, Inc. (NASD... [Published Galaxy Stocks - May 20 2013]
‘Love Hormone’ Drug Promises Safer Births Follo... [Published Bloomberg - May 19 2013]
Oramed Sweeps Past Worldwide Giants With The Fi... [Published Seeking Alpha - May 19 2013]
MannKind Corporation (MNKD): Why Have Shares Mo... [Published InsiderMonkey.com - May 19 2013]
The Best- And Worst- Performing Biotech Stocks,... [Published Forbes.com - May 19 2013]
Bionic eye maker has vision of the future [Published Knox News Sentinel - May 19 2013]
5 of Last Week's Biggest Winners [Published Motley Fool - May 19 2013]
1 Giant Leap for MannKind [Published Motley Fool - May 18 2013]
Why MannKind's Afrezza Will Succeed Where Pfize... [Published BioPortfolio - May 18 2013]
Why MannKind's Afrezza Will Succeed Where Pfize... [Published Zecco - May 18 2013]
Why MannKind's Afrezza Will Succeed Where Pfize... [Published Seeking Alpha - May 18 2013]
Puma, Mannkind Among Week’s Biggest Movers [Published Los Angeles Business Journal - May 18 2013]
Form 4 MANNKIND CORP For: May 15 Filed by: PFEF... [Published Street Insider - May 17 2013]
XBiotech Takes Aim at Inflammation That Weakens... [Published Xconomy - May 17 2013]
MannKind to Present at Bank of America Merrill ... [Published NewsRX - May 17 2013]
News Recap: National Bank of Greece (ADR)(NYSE:... [Published SBWire - May 16 2013]
HIMAX TECHNOLOGIES, INC.: HIMX, CSCO, SPWR and ... [Published 4 Traders - May 16 2013]
Shares of MannKind Rise to a New 52-... [Published Financial News Network online - May 16 2013]
A Second Chance For Mannkind Co. (MNKD)? [Published I Stock Analyst - May 15 2013]
Activision Halts Vivendi Talks and 2 More Heavi... [Published Wall St. Cheat Sheet - May 15 2013]
Activision Halts Vivendi Talks and 2 More Heavi... [Published Wall St. Cheat Sheet - May 15 2013]
Notable 52-Week Highs and Lows of the Day 05/15... [Published Street Insider - May 15 2013]
Shares of MannKind Rise to a New 52-Week High [Published Individual.com - May 15 2013]
Top Analysts Action: VAL, AEO, RWT, NBL, HK [Published BayStreet.ca - May 15 2013]
Healthcare Review: Sangamo Biosciences, MannKin... [Published BioMedReports - May 15 2013]
Modified Shares in Medical Care Industry : BMY,... [Published SBWire - May 15 2013]
Notable Analyst Rating Changes 05/15: (ARO) (GP... [Published Street Insider - May 15 2013]

Blogs

sort by: Date \| Relevance
Can Pfizer’s Love Hormone Cut Down Maternal Mor... [Published Wall St. Cheat Sheet - 17 hours ago] Oxytocin is a brain chemical that helps the uterus contract after birth and is occasionally referred to as the “love hormone” because of its role in couples’ bonding. Used preventatively, it can actually cut the rate of post-delivery bleeding complications ...
Can Pfizer’s Love Hormone Cut Down Maternal Mor... [Published Wall St. Cheat Sheet - 17 hours ago] Oxytocin is a brain chemical that helps the uterus contract after birth and is occasionally referred to as the “love hormone” because of its role in couples’ bonding. Used preventatively, it can actually cut the rate of post-delivery bleeding complications ...
Activision Halts Vivendi Talks and 2 More Heavi... [Published Wall St. Cheat Sheet - May 15 2013] Activision Blizzard ( NASDAQ:ATVI ): Current price $14.90Knowledgeable sources say that the video game publisher has halted talks on repurchasing shares held by its parent company Vivendi, amid a dispute over price adding that Activision was considering the ...
Activision Halts Vivendi Talks and 2 More Heavi... [Published Wall St. Cheat Sheet - May 15 2013] Activision Blizzard ( NASDAQ:ATVI ): Current price $14.90 Knowledgeable sources say that the video game publisher has halted talks on repurchasing shares held by its parent company Vivendi, amid a dispute over price adding that Activision was considering the ...
Human Factors Session Spotlight: Linking HF to ... [Published Future of BioPharma - May 01 2013] Clinical studies on the drug component of many drug-device combination products are conducted simultaneously, yet independently of the human factors studies. If there is a delay on one of these studies, the market launch of the combination product ...

Press Releases

sort by: Date \| Relevance
MannKind Corporation Reports 2013 First Quarter... [Published Business Wire Health News - May 09 2013]
MannKind to Present at Bank of America Merrill ... [Published Business Wire Health News - May 08 2013]
MannKind Corporation to Hold 2013 First Quarter... [Published Business Wire - May 02 2013]
MannKind Corporation to Hold 2013 First Quarter... [Published Business Wire Science: Science News - May 02 2013]
MannKind, Ariad Pharma, Ziopharm Oncology, Gale... [Published Financial Services - Apr 23 2013]